全文获取类型
收费全文 | 57048篇 |
免费 | 5736篇 |
国内免费 | 20篇 |
专业分类
62804篇 |
出版年
2023年 | 271篇 |
2022年 | 599篇 |
2021年 | 1033篇 |
2020年 | 646篇 |
2019年 | 807篇 |
2018年 | 994篇 |
2017年 | 859篇 |
2016年 | 1544篇 |
2015年 | 2655篇 |
2014年 | 2688篇 |
2013年 | 3393篇 |
2012年 | 3942篇 |
2011年 | 3498篇 |
2010年 | 2355篇 |
2009年 | 2072篇 |
2008年 | 2791篇 |
2007年 | 2766篇 |
2006年 | 2474篇 |
2005年 | 2356篇 |
2004年 | 2231篇 |
2003年 | 1875篇 |
2002年 | 1874篇 |
2001年 | 1330篇 |
2000年 | 1318篇 |
1999年 | 1211篇 |
1998年 | 730篇 |
1997年 | 655篇 |
1996年 | 644篇 |
1995年 | 601篇 |
1994年 | 548篇 |
1993年 | 560篇 |
1992年 | 1051篇 |
1991年 | 785篇 |
1990年 | 807篇 |
1989年 | 798篇 |
1988年 | 690篇 |
1987年 | 619篇 |
1986年 | 629篇 |
1985年 | 735篇 |
1984年 | 560篇 |
1983年 | 434篇 |
1982年 | 359篇 |
1981年 | 330篇 |
1980年 | 274篇 |
1979年 | 397篇 |
1978年 | 356篇 |
1977年 | 249篇 |
1976年 | 242篇 |
1974年 | 302篇 |
1973年 | 259篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
891.
892.
893.
Leigh syndrome is a mitochondrial disease with considerable clinical and genetic variation. We present a 16-year-old boy with Leigh-like syndrome and broad developmental retardation, parkinsonism and hypogonadism. Sequencing of the entire mitochondrial DNA from blood revealed the m.4296G>A mutation in the MT-TI gene. The mutation was heteroplasmic with a 95% proportion of the mutant genome, while the proportion was 58% in the blood of the patient's clinically healthy mother. Our results suggest that m.4296G>A is pathogenic in humans, and that the phenotype related to this change includes Leigh-like syndrome in adolescence with parkinsonism and hypogonadism, in addition to the previously reported early infantile Leigh syndrome. 相似文献
894.
895.
M. Sunamura N. ter Hoeve H. J. G. van den Berg-Emons M. Haverkamp K. Redekop M. L. Geleijnse H. J. Stam E. Boersma R. T. van Domburg 《Netherlands heart journal》2013,21(7-8):324-330
The majority of cardiac rehabilitation (CR) referrals consist of patients who have survived an acute coronary syndrome (ACS). Although major changes have been implemented in ACS treatment since the 1980s, which highly influenced mortality and morbidity, CR programs have barely changed and only few data are available on the optimal CR format in these patients. We postulated that standard CR programs followed by relatively brief maintenance programs and booster sessions, including behavioural techniques and focusing on incorporating lifestyle changes into daily life, can improve long-term adherence to lifestyle modifications. These strategies might result in improved (cardiac) mortality and morbidity in a cost-effective fashion. In the OPTImal CArdiac REhabilitation (OPTICARE) trial we will assess the effects of two advanced and extended CR programs that are designed to stimulate permanent adaption of a heart-healthy lifestyle, compared with current standard CR, in ACS patients. We will study the effects in terms of cardiac risk profile, levels of daily physical activity, quality of life and health care consumption. 相似文献
896.
897.
898.
Izelle Smuts Francois H. van der Westhuizen Roan Louw Lodewyk J. Mienie Udo F. H. Engelke Ron A. Wevers Shayne Mason Gerhard Koekemoer Carolus J. Reinecke 《Metabolomics : Official journal of the Metabolomic Society》2013,9(2):379-391
The diagnosis of respiratory chain deficiencies (RCDs) is complicated and the need for a diagnostic biomarker or biosignature has been widely expressed. In this study, the metabolic profile of a selected group of 29 RCD patients, with a predominantly muscle disease phenotype, and 22 controls were investigated using targeted and untargeted analyses of three sub-sections of the human metabolome, including urinary organic acids and amino acids [measured by gas chromatography–mass spectrometry (GC–MS)], as well as acylcarnitines (measured by electrospray ionization tandem MS). Although MS technologies are highly sensitive and selective, they are restrictive by being applied only to sub-sections of the metabolome; an untargeted nuclear magnetic resonance (NMR) spectroscopy approach was therefore also included. After data reduction and pre-treatment, a biosignature comprising six organic acids (lactic, succinic, 2-hydroxyglutaric, 3-hydroxyisobutyric, 3-hydroxyisovaleric and 3-hydroxy-3-methylglutaric acids), six amino acids (alanine, glycine, glutamic acid, serine, tyrosine and α-aminoadipic acid) and creatine, was constructed from uni- and multivariate statistical analyses and verified by cross-validation. The results presented here provide the first proof-of-concept that the metabolomics approach is capable of defining a biosignature for RCDs. We postulate that the composite of organic acids ≈ amino acids > creatine > betaine > carnitines represents the basic biosignature for RCDs. Validated through a prospective study, this could offer an improved ability to assign individual patients to a group with defined RCD characteristics and improve case selection for biopsy procedures, especially in infants and children. 相似文献
899.
Sanne R. Martens-de Kemp Arjen Brink Marijke Stigter-van Walsum J. Mirjam A. Damen François Rustenburg Thijs Wu Wessel N. van Wieringen Gerrit Jan Schuurhuis Boudewijn J.M. Braakhuis Monique Slijper Ruud H. Brakenhoff 《Stem cell research》2013,10(3):477-488
Patients with advanced head and neck squamous cell carcinomas (HNSCCs) are often treated with concomitant chemotherapy and radiotherapy, but only 50% is cured. A possible explanation for treatment failure is therapy resistance of the cancer stem cells (CSCs). The application of compounds specifically targeting these CSCs, in addition to routinely used therapeutics, would likely improve clinical outcome. We demonstrate that the previously described monoclonal antibody K984 recognizes the CD98 cell surface protein, which is specifically expressed by cells forming the squamous basal cell layer, the region where the squamous stem cells reside. Moreover, CD98 is highly resistant to the proteolytic enzymes required for CSC enrichment procedures. We show that CD98high cells, in contrast to CD98low cells, are able to generate tumors in immunodeficient mice, indicating that CD98high cells have stem cell characteristics. Furthermore, the CD98high subpopulation expresses high levels of cell cycle control and DNA repair genes, while the CD98low fraction shows expression patterns that represent the more differentiated cells forming the bulk of the tumor. CD98 is a promising CSC enrichment marker in HNSCC. Our data support the CSC concept in head and neck cancer and the potential relevance of these cells for treatment outcome. 相似文献
900.
Rogier C. J. de Jonge Marieke S. Sanders Caroline B. Terwee Martijn W. Heymans Reinoud J. B. J. Gemke Irene Koomen Lodewijk Spanjaard A. Marceline van Furth 《PloS one》2013,8(3)